nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
|
Chan, Shing |
|
2019 |
12 |
5 |
p. 788-799 |
artikel |
2 |
Arterial Spin Labeling for Glioma Grade Discrimination: Correlations with IDH1 Genotype and 1p/19q Status
|
Wang, Ning |
|
2019 |
12 |
5 |
p. 749-756 |
artikel |
3 |
Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
|
Wei, Xiao |
|
2019 |
12 |
5 |
p. 733-738 |
artikel |
4 |
Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
|
Zhou, Dabo |
|
2019 |
12 |
5 |
p. 764-774 |
artikel |
5 |
Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer
|
Pandey, Ritu |
|
2019 |
12 |
5 |
p. 714-725 |
artikel |
6 |
Diffusion-weighted magnetic resonance imaging is useful for the response evaluation of chemotherapy and/or radiotherapy to recurrent lesions of lung cancer
|
Usuda, Katsuo |
|
2019 |
12 |
5 |
p. 699-704 |
artikel |
7 |
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia
|
Lopes, Bruno A. |
|
2019 |
12 |
5 |
p. 726-732 |
artikel |
8 |
Isolated 5′ Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature
|
Guyard, Alice |
|
2019 |
12 |
5 |
p. 784-787 |
artikel |
9 |
LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus–Transformed B Cells
|
Yun, Sun-mi |
|
2019 |
12 |
5 |
p. 775-783 |
artikel |
10 |
Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
|
Willumsen, Nicholas |
|
2019 |
12 |
5 |
p. 693-698 |
artikel |
11 |
Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab
|
Economopoulou, Panagiota |
|
2019 |
12 |
5 |
p. 739-748 |
artikel |
12 |
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations
|
Shi, Puyu |
|
2019 |
12 |
5 |
p. 705-713 |
artikel |
13 |
Treatment of Locally Advanced Nasopharyngeal Carcinoma by Helical Tomotherapy: An Observational, Prospective Analysis
|
Liu, Zhigang |
|
2019 |
12 |
5 |
p. 757-763 |
artikel |